Innoviva Inc Revenue per Employee (INVA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Innoviva Inc   (NASDAQ: INVA)
 

Innoviva Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 28.39% in the second quarter 2026, year on year to cumulative value of $421 million, Innoviva Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,645,472. The productivity of Innoviva Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 13 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 243, from total ranking in previous quarter at 856. Innoviva Inc has 159 employees.


What is Sales per Employee Ratio?







INVA Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 28.39 % 11.71 % 21.66 % -5.55 % -28.6 %
Sales per Employee (TTM) $ 2,645,472 2,479,151 2,419,289 2,296,478 2,333,616
INVA's Total Ranking # 243 # 856 # 1106 # 718 #
Seq. Revenue Change 31.66 % -17.17 % 9.08 % 7.94 % 14.55 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 14
Overall Market # 243

Revenue per Employee Statistics
High Average Low
$ 2,628,126 $ 1,542,707 $ 19,497
(Dec 31 2024)   (June 30. 2014)



Financial Statements
Innoviva Inc 's Revenue MRQ $ 120 Millions Visit INVA's Income Statement
Innoviva Inc 's Revenues TTM $ 421 Millions Visit INVA's aggregate revenue growth
What are INVA's Sales? Visit INVA's Sales by Segment




Other Ratios
Innoviva Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
INVA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for INVA's Competitors
Revenue per Employee for INVA's Suppliers
Revenue per Employee for INVA's Customers

You may also want to know
INVA's Sales Growth Rates INVA's Pe Price to earnings ratio INVA's Receivables Turnover Ratio INVA's Stock Quote
INVA's Net Income Growth Rates INVA's Ps Price to Sales ratio INVA's Sales per Employee INVA's Asset Turnover Ratio
INVA's Net Margin INVA's Pb Price to Book ratio INVA's Financial Strength Ratios INVA's Dividend Payout Ratio
Date modified: 2026-09-11T09:45:34+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Nuvation Bio Inc   3,943,046.51 $ 169.551  Million 43 
Halozyme Therapeutics Inc   3,933,186.76 $ 1,663.738  Million 423 
Ironwood Pharmaceuticals inc   3,893,160.00 $ 389.316  Million 100 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million
Innoviva Inc   2,645,471.70 $ 420.630  Million 159 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.